Label-free detection is proving to be a highly sensitive measurement method for endogenous targets in live cell assays. It eliminates the need for engineered cells, tags, dyes, or specialized reagents. Label-free detection technology reduces the resources required for simplifying assay design, assay development, minimizing liabilities created by the use of labels, and studies molecular interactions without modifying molecules of interest. It also eliminates the problem with secondary detection and increases sensitivity & specificity. Label-free technologies enable drug discovery researchers to operate a wide formation of target types that play a role in studying cancer, obesity, inflammation, diabetes, neuromuscular disorders, pathological pain, and psychiatric disorders. Additionally, label-free assays eliminate issues such as photobleaching that are common in most fluorescent tags. They also cut off the need for optical filters and reduce the restriction on distance dependence of the binding interaction that plague some fluorescent resonance energy transfer (FRET) assays.
The global Label-free detection market was valued at USD 1,099.79 million in 2019 and projected to reach USD 2,440.44 million in 2027 at a CAGR of 11.2% during the forecast period, 2020–2027. The market revenue can be attributed to increasing drug discovery activities, rising pharmaceutical industries & partnerships with CROs, and raising awareness of global label-free detection technology. Further, this technology is highly recommended in drug discovery and biochemical screening applications, which involve protein-small-molecule interactions, protein-peptide, Protein-DNA, and protein-protein analysis. Increasing applications in many fields, including biotherapeutic discovery &development for epitope binding, affinity ranking, crude antibody screening, and bioprocessing to rapidly monitor protein expression in crude cell culture supernatants, are anticipated to fuel the demand for label-free detection technology across the globe in the coming years. Additionally, the technology allows researchers to explore biomolecular interactions in direct, real-time monitoring of binding interaction, label-free and high-throughput manner is positively impacting the demand for label-free detection technology in the future period. Some of the label-free market drives are the advent of technology with the availability of label-free screening, label-free cellular microplates, and biochemical assays. This is ideal for use in drug discovery, enabling the study of GPCRs and cell signaling. Furthermore, the increasing incidence of chronic illness and rising demand for drugs will promulgate the global Label-free detection technology market share.
The Label-free detection technology is highly sensitive, reliable, and robust. It monitors biomolecular interactions and simplifies the bioassays by eliminating the need for secondary reactants. Moreover, this technology has revolutionized pharmaceutical analysis, cellular detection, biomolecular characterization, disease diagnostics, screening of potential drugs, and environmental monitoring. Label-free technology is mainly involved in drug screening and highly desirable for molecular transport through the blood-brain barrier and currently emerging in diseases diagnosis and treatment. Hence, it is clear that the upcoming future of pharmaceutical & biopharmaceutical industries will heavily rely upon the development of Label-free technologies.
Based on product, the global label-free detection market is classified into consumables and instruments. The consumables segment is further divided into reagents, microplates, biosensor chips, and kits. The Instrument’s segment accounted for the highest market share in 2019. It is attributable to advanced use in drug discovery and the high prices of Instruments. The biosensor chips segment will garner a significant market share in the forecast period. It is owing to the ability to monitor molecules’ interaction in real-time.
Based on the technology, the global label-free detection market is segregated into biolayer interferometry, isothermal titration calorimetry, differential scanning calorimetry, surface plasmon resonance, and other detection technologies. The surface plasmon resonance segment held a higher revenue share in 2019 and is projected to dominate the Label-free detection market by 2027. It is due to its wide use in biosensing, analysis of biomolecular interactions, and study of vaccines against harmful microorganisms. Moreover, it is cost-effective technology.
The bio- layer interferometry segment will grow with a lucrative growth rate in the forecast period. It is an optical analytical technique that can offer accurate, quick, and sensitive determination of kinetics, affinity, and activity of complex formation, doesn’t require any washing of samples or fluorescent dyes and provides free assay buffer choices.
Based on the application, the global label-free detection market is segregated into binding kinetics, binding thermodynamics, endogenous receptor detection, hit confirmation, lead generation, and others. The binding kinetics segment held a higher revenue share in 2019 and projected to dominate the Label-free detection market by 2027. It is primarily attributed to the importance of clinical efficacy and interaction between drug targets. Moreover, it is used in developing drugs where shorter durations of action are desirable.
The Binding thermodynamics segment will grow with a lucrative growth rate in the forecast period. It is due to help in the study of drug design and screening.
Based on end-user, the global label-free detection market is classified into pharmaceutical & biotechnology companies, CROs, academic and research institutes. The pharmaceutical & biotechnology companies segment will garner higher market potential by 2027. It is due to increasing drug discovery and rising R&D expenditure.
The CROs will be the fastest-growing segment in the forecast period due to the growth of the medical industry and the rising need for clinical trials and research support services.
The global label-free detection market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa by geography. North America is to account for a significant share by 2027 in the Label-free detection market. The growth in the region can be attributed to the growing health care expenditure, increasing chronic diseases, and research activities for drug discovery & development.
The Asia Pacific is expected to provide significant growth opportunities due to the rapid adoption of advanced diagnostic technology and improving healthcare infrastructure in the countries like China and India.
Companies such as Thermo Fisher Scientific Inc., PerkinElmer, Danaher Corporation, F. Hoffmann-La Roche Ltd, Waters Corporation, Hitachi Ltd, General Electric Company, Malvern Panalytical Ltd, Sartorius Stedim Biotech S.A., Mettler-Toledo International Inc, HORIBA Ltd, Corning Incorporated, AMETEK Inc. and Agilent Technologies Inc. are the key players in the global label-free detection market.
By Product
By Technology
By Application
By End-User
By Region
Global Label-free detection Market
Analyst support
After evaluating your requirements and addressing your technical problems, the expert analyst will resolve your query directly.
Customer satisfaction
According to your needs, our expert team will assist you with the capabilities, services, and proper research needs to be required and customize the report accordingly.
Inimitable expertise
Our expert team will create unrivaled reviews to provide you with a deep understanding of the reports.
Assured quality
We have created a systematic way to determine standards and satisfy your expectations.
Instant delivery
Unlike others, we provide you a great deal of instant delivery in the form of PDF/PPT/Word Doc directly to your email address within 24 hours after receiving full payment.
Privacy policy
We understand the inkling of your privacy, we will never misuse your email address.
Custom research service
We are giving you an opportunity through which you can directly ask our expert analyst to customize an exclusive study of the report to serve your research needs.
Quality & accuracy
We provide you with the accurate quality of the customized study of an exclusive report according to your research need.
Data visualization
As the business world’s growing faster every day, we understand the value of data management. We will create the reports by keeping all the visual data sets and metrics in the charts.
Information security
We truly respect your privacy and promise to keep your personal and confidential information safe and secure.